MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA

疟疾的非灭菌免疫机制

基本信息

  • 批准号:
    3125258
  • 负责人:
  • 金额:
    $ 19.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1975
  • 资助国家:
    美国
  • 起止时间:
    1975-06-01 至 1988-08-31
  • 项目状态:
    已结题

项目摘要

Resistance to acute Plasmodium chabaudi adami malaria in mice is mediated by non-antibody mechanisms of immunity. Adoptive cell transfer studies demonstrate that T cells are required for both the induction and expression of this form of immunity. The purpose of the proposed study is to determine which Lyt subsets of splenic T cells are involved. Lyt subsets of spleen cells from euthymic mice prepared by selective killing with anti-Lyt monoclonal antibody in the presence of complement or by panning rat anti-mouse Lyt coated spleen cells on petri plates coated with anti-rat Ig will be injected into histocopatible athymic nude mice prior to challenge with P. chadaudi adami. The resulting parasitemias will be plotted against time in order to see which Lyt subset(s) suppress infection. Also, Lyt subsets of spleen cells prepared from the spleens of P. chabaudi adami immune B-cell deficient mice as well as immunologically intact mice will be tested for their ability to adoptively transfer immunity to P chabaudi adami infection to irradiated homologous recipients. In order to define mechanisms of nonantibody immunity to P. chabaudi adami T-cell clones and T-cell hybrids constructed with spleen cells of immune mice will be tested for their capacity to protect nude mice against challenge infection. Similarly, soluble factors from protective cell lines will be characterized and tested for their ability to mediate protection in nude mice. Two additional parameters will be investigated in order to determine whether they can be correlated with protection achieved with Lyt fraction T-cell clones and T-cell hybrids. These are splenic macrophage activation as determined by chemiluminescence and the activation of splenic reticular cells. Finally, P. chabaudi adami antigens will be fractionated and characterized in terms of their ability to activate protecting cell populations as well as to induce protection in mice by immunization. This approach, which will attempt to correlate protection with cell function, factor-production, and effector cell activation, may provide a coherent physiologic picture of events which must transpire for the expression of antibody-independent immunity.
介导小鼠对急性夏波蒂疟原虫疟疾的抗性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM Paul WEIDANZ其他文献

WILLIAM Paul WEIDANZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM Paul WEIDANZ', 18)}}的其他基金

Plasmodium falciparum infection of the humanized NOD/SCID/IL2r[gamma][null] mouse
人源化 NOD/SCID/IL2rγ[null] 小鼠的恶性疟原虫感染
  • 批准号:
    7570003
  • 财政年份:
    2008
  • 资助金额:
    $ 19.62万
  • 项目类别:
Plasmodium falciparum infection of the humanized NOD/SCID/IL2r[gamma][null] mouse
人源化 NOD/SCID/IL2rγ[null] 小鼠的恶性疟原虫感染
  • 批准号:
    7470884
  • 财政年份:
    2008
  • 资助金额:
    $ 19.62万
  • 项目类别:
Mechanisms of Nonsterilizing Immunity in Malaria
疟疾的非灭菌免疫机制
  • 批准号:
    7384460
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
疟疾的非灭菌免疫机制
  • 批准号:
    2059913
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
疟疾的非灭菌免疫机制
  • 批准号:
    6372958
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
疟疾的非灭菌免疫机制
  • 批准号:
    3125261
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
疟疾的非灭菌免疫机制
  • 批准号:
    3125262
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
Mechanisms of Nonsterilizing Immunity in Malaria
疟疾的非灭菌免疫机制
  • 批准号:
    7215208
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
Mechanisms of Nonsterilizing Immunity in Malaria
疟疾的非灭菌免疫机制
  • 批准号:
    6967394
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
疟疾的非灭菌免疫机制
  • 批准号:
    2059914
  • 财政年份:
    1975
  • 资助金额:
    $ 19.62万
  • 项目类别:

相似海外基金

Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.62万
  • 项目类别:
    Research Grant
Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014452/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.62万
  • 项目类别:
    Research Grant
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
  • 批准号:
    10634775
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
Chemical Biology Strategies to Resolve Plasmodium Heat Shock Protein Function
解决疟原虫热休克蛋白功能的化学生物学策略
  • 批准号:
    10734886
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
  • 批准号:
    10666280
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
  • 批准号:
    10888455
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
  • 批准号:
    MR/X030202/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
    Research Grant
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
  • 批准号:
    10079676
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
    EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
  • 批准号:
    10734028
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
  • 批准号:
    10564073
  • 财政年份:
    2023
  • 资助金额:
    $ 19.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了